Skip to main content
Fig. 12 | Cancer Nanotechnology

Fig. 12

From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation

Fig. 12

Biodistribution of vincristine after a single intravenous injection (A) and nanoformulations of VC-loaded in TCs-HA (B) in rats. Each drug was administered to immunosuppressed rats at a dose of 1 mg/kg, and the data were presented where n = 10, mean ± SD, p ≤ 0.05

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us